Hardman & Co Analyst Q&A: Pantheon International (LON:PIN)
19 September 2019
National HealthCare Corporation (NYSE: NHC) has recently caught the attention of investors as it reached its 52-week high at $171.15, marking a significant climb from the previous low of $89.91...
UFP Technologies, Inc. (NASDAQ: UFPT) stands out in the healthcare sector, particularly within the medical devices industry. With a market cap of $1.58 billion, the company has carved out a..
LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector specializing in medical instruments and supplies, has been capturing investor interest with its robust growth metrics and favorable..
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its focus on developing therapies for rare neurological diseases. The company’s flagship offering, WAKIX (pitolisant), targets..
Immunocore Holdings plc (NASDAQ: IMCR) has captured significant attention in the biotechnology sector, drawing investor interest with its promising pipeline and a robust potential upside of 99%. As a player..
Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, stands at the forefront of developing innovative immunotherapies aimed at tackling cancer and other challenging diseases. Headquartered in Redwood..
Biohaven Ltd. (BHVN), a dynamic player in the biotechnology sector, is capturing investor attention with its promising pipeline of therapies and a remarkable potential upside of 77.29% according to analyst..
Omnicell, Inc. (NASDAQ: OMCL) stands out as a compelling opportunity for investors seeking to tap into the healthcare technology sector. With a market capitalization of $1.89 billion, Omnicell operates in..
GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing opportunity for investors seeking exposure to the healthcare sector, particularly in the health information services industry. With a market capitalization of $753.97..
NovoCure Limited (NASDAQ: NVCR), a promising player in the healthcare sector, is drawing investor attention with its innovative approach to cancer treatment. As a Swiss medical device company, NovoCure focuses..
LifeStance Health Group, Inc. (LFST) is making waves in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Scottsdale, Arizona, LifeStance provides vital outpatient mental health services..
As investors continue to navigate the turbulent waters of the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing opportunity with a notable potential upside of 83.57%. Headquartered in..
Centessa Pharmaceuticals plc (NASDAQ: CNTA) offers an intriguing opportunity for investors seeking exposure to the innovative and high-growth potential of the biotechnology sector. With a market capitalization of $3.92 billion,..
Clover Health Investments, Corp (NASDAQ: CLOV) has been a focal point for investors in the healthcare sector, particularly those interested in companies that blend technology with traditional healthcare plans. Based..
Investors are increasingly turning their attention to GRAIL, Inc. (GRAL), a pioneering healthcare company that is making significant strides in the diagnostics and research industry. With a market capitalization of..
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biopharmaceutical firm, is currently capturing investor attention with its significant growth potential and a robust lineup of analyst endorsements. Operating within the..
CG Oncology, Inc. (NASDAQ: CGON) stands as a formidable player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $4.77 billion, this Irvine, California-based company..
For investors seeking high-growth opportunities in the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) offers an intriguing proposition with its remarkable potential upside. As a clinical-stage biopharmaceutical company, Janux is..
Ascentage Pharma Group International (AAPG), a pioneering force in the biotechnology industry, is capturing investor attention with its ambitious pipeline of therapies poised to address critical healthcare needs, ranging from..
